24.07.2018 22:40:00

Catalent Pharma Solutions, Inc. -- Moody's: Catalent's plan to use equity offering proceeds for debt repayment is credit positive

Announcement: Moody's: Catalent's plan to use equity offering proceeds for debt repayment is credit positive

Vollständigen Artikel bei Moodys lesen